Embecta Corp.
Organization details
- Legal name
- Embecta Corp.
- Former names
- Berra Newco, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Parsippany
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- EMBC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001872789
- EIN
- 87-1583942
Board of directors
-
Carrie L. Anderson · DirectorSince 2023
-
Christopher R. Reidy · DirectorSince 2022
-
Claire Pomeroy · DirectorSince 2023
-
David Albritton · DirectorSince 2023
-
David F. Melcher · DirectorSince 2022
-
Devdatt Kurdikar · Director · President and CEOSince 2023
-
Karen Prange · DirectorSince 2023
-
Milton Mayo Morris · DirectorSince 2023
-
Robert J. Hombach · DirectorSince 2023
Chief executives
Director election results
Annual meeting of February 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.4%
-
98.1%
-
98.6%
-
99.5%
-
99.8%
Board connections
6 of this board's directors also sit on 10 other boards. 8 are in the same sector.
-
AtriCure Inc. Same sectorvia Karen Prange
-
BioMarin Pharmaceutical Inc. Same sectorvia Robert J. Hombach
-
Encompass Health Corporation Same sectorvia Christopher R. Reidy
-
Haemonetics Corporation Same sectorvia Claire Pomeroy
- via Robert J. Hombach
-
Myomo Inc. Same sectorvia Milton Mayo Morris
- via Milton Mayo Morris
-
Outset Medical Inc. Same sectorvia Karen Prange
-
Seaport Therapeutics Inc. Same sectorvia Robert J. Hombach
-
Zimmer Biomet Holdings Inc. Same sectorvia Devdatt Kurdikar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $557,850
- 4 purchases by 4 insiders
- Sold, last 12 months
- $37,003
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Milton Mayo Morris Director | Open-market sale | −6,293 | $5.88 | $37,003 |
| Aug 12, 2026 | Elguicze Jacob Officer (SVP and CFO) | Open-market purchase | +20,000 | $4.67 | $93,400 |
| Aug 12, 2026 | Robert J. Hombach Director | Open-market purchase | +45,000 | $4.97 | $223,650 |
| Aug 12, 2026 | Mann Jeffrey Z Officer (Pres, Pharm Svc&Prod Mgmt, CLO) | Open-market purchase | +20,000 | $4.99 | $99,800 |
| Aug 12, 2026 | Devdatt Kurdikar Director, Officer (President and CEO) | Open-market purchase | +30,000 | $4.70 | $141,000 |
| Aug 9, 2026 | Casner Jean Officer (Chief Human Resources Officer) | Shares withheld for tax | −1,480 | $4.42 | $6,542 |
| Jun 1, 2026 | Roth Anthony M. Officer (VP, Chief Accounting Officer) | Grant or award | +30,000 | — | — |
| Feb 11, 2026 | Carrie L. Anderson Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Robert J. Hombach Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Milton Mayo Morris Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Karen Prange Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Claire Pomeroy Director | Grant or award | +22,841 | — | — |
| Feb 11, 2026 | Christopher R. Reidy Director | Grant or award | +22,841 | — | — |
| Nov 26, 2025 | Roth Anthony M. Officer (Chief Accounting Officer) | Grant or award | +32,817 | — | — |
| Nov 26, 2025 | Casner Jean Officer (Chief Human Resources Officer) | Grant or award | +38,783 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Embecta Corp.
Who is the CEO of Embecta Corp.?
Devdatt Kurdikar is Embecta Corp.'s President and CEO.
How many directors are on Embecta Corp.'s board?
Embecta Corp.'s board has 9 directors: Carrie L. Anderson, Christopher R. Reidy, Claire Pomeroy, David Albritton, David F. Melcher, Devdatt Kurdikar, Karen Prange, Milton Mayo Morris and Robert J. Hombach.
Are Embecta Corp. insiders buying or selling shares?
Over the last 12 months, Embecta Corp. insiders bought $557,850 of shares in 4 purchases and sold $37,003 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="embecta-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.